INTRODUCTIONTargeted therapies in particular epidermal growth factor (EGFR)-inhibitors have emerged as the primary therapy in advanced solid tumor malignancies including colorectal, pancreas, head and neck cancers, and non-small cell lung…
Read More
INTRODUCTIONCellulite is a localized alteration of skin topography (eg, dimpling) and affects 80% to 98% of postpubertal women of all ages and ethnicities.1,2 Although the pathophysiology of cellulite has not…
Read More
INTRODUCTIONTelangiectasias are small blood vessels, typically measuring 0.1 to 1.0 mm in diameter, which may be of venular, capillary, or arteriolar origin.1,2 Telangiectasias develop secondary to a variety of factors…
Read More
INTRODUCTIONOnychomycosis—a chronic and recurring fungal infection of the fingernails or toenails—can occur in children, ranging in prevalence from 0.35%–5.5% worldwide.1 Though less common in children than adults,1 onychomycosis has been…
Read More
INTRODUCTIONInjection of hyaluronic acid (HA) dermal fillers is one of the most frequently performed aesthetic procedures.1 HA fillers exist in many different formulations differing in HA concentration, particle size and…
Read More
INTRODUCTIONMelasma is a common, acquired disorder of skin hyperpigmentation that characteristically presents with symmetric brown macules and patches on the cheeks, forehead, and chin. The highest prevalence is seen in…
Read More
Prospective Analysis in Patients With HAE Under Prophylaxis With Lanadelumab: A Real-life Experience
INTRODUCTIONPatients suffering from the bradykinin-induced genetic disease hereditary angioedema (HAE) show recurrent swelling of subcutaneous and submucosal structures. The attacks can affect almost every part of the body and may…
Read More
BACKGROUNDHyaluronidase is an enzyme used in ophthalmic surgery and dermatology. Its use is well-established and is the standard approach in dissolving Hyaluronic acid (HA) fillers (off-label) both in overcorrection and…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a skin disorder characterized by chronic relapsing pruritic eczema resulting from altered skin barrier function and neuroimmune dysregulation.1 Moderate-to-severe AD can result in functional impairment, sleep…
Read More
INTRODUCTIONAtopic Dermatitis (AD) is a common, chronic, inflammatory dermatosis and skin disease that follows a relapsing pattern and requires a dynamic and stepwise approach to management.1,2 AD is often associated…
Read More
INTRODUCTIONCommon warts, also known as verruca vulgaris, are benign skin and mucosal growths caused by human papillomavirus (HPV) infection of keratinocytes.1 Common warts can occur at virtually any anatomic location,…
Read More
INTRODUCTIONAtopic dermatitis (AD) is a pruritic, inflammatory skin disease that affects approximately 5–30% of children and 2–10% of adults.1-3 The pathogenesis of AD involves a complex interplay of skin barrier…
Read More
